| Literature DB >> 8599966 |
T Jones1, D A Silbersweig, E Stern, L Schnorr, J Seaward, J C Clark, A A Lammertsma, S Grootoonk.
Abstract
An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8599966 DOI: 10.1007/bf00837633
Source DB: PubMed Journal: Eur J Nucl Med ISSN: 0340-6997